FDAnews
www.fdanews.com/articles/71881-drug-merger-strengthens-local-plant

Drug Merger Strengthens Local Plant

May 4, 2005

In recent years, the Grand Island plant of Fujisawa Healthcare Inc. was the only U.S. manufacturing site and one of three distribution centers for its Japanese owner. Since the April 1 merger of Fujisawa's parent with another Japanese drug company, however, the operation has acquired more responsibilities, a heightened status and improved prospects. Under the new name, Astellas Pharma Manufacturing Inc., the facility continues as a manufacturing plant. But it also has become the U.S. distribution and procurement hub for its Tokyo-based parent, Astellas Pharma Inc.

Buffalo Business First (http://www.bizjournals.com/buffalo/stories/2005/05/02/story1.html)